| Dr Douglas Courtney Maxwell, DMD | |
|
2415 Andover Dr, Valdosta, GA 31602-1280 | |
| (229) 671-1900 | |
| (229) 671-1999 |
| Full Name | Dr Douglas Courtney Maxwell |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 2415 Andover Dr, Valdosta, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205999133 | NPI | - | NPPES |
| 9183256 | Other | GA | DORAL |
| 000963256A | Medicaid | GA | |
| 986622 | Other | GA | UNITED CONCORDIA |
| 100049 | Other | GA | AVESIS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 11562 (Georgia) | Primary |
| 1223G0001X | Dentist - General Practice | 11562 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Courtney Maxwell, DMD 2415 Andover Dr, Valdosta, GA 31602-1280 Ph: (229) 671-1900 | Dr Douglas Courtney Maxwell, DMD 2415 Andover Dr, Valdosta, GA 31602-1280 Ph: (229) 671-1900 |
News Archive
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don't get it.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced interim results of CLL-009, a study evaluating three starting doses of REVLIMID (lenalidomide), followed by step-wise dose escalation as tolerated in patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 5 days ago
Dr. Joel Stites, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 103 W Cranford Ave, Valdosta, GA 31602 Phone: 229-249-0717 | |
Dr. Richard Ferrell Brooks, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 101 Northside Dr, C, Valdosta, GA 31602 Phone: 229-247-2225 Fax: 229-247-2295 | |
Dr. Robert Mark Pearson, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3227 N. Oak St. Ext., Valdosta, GA 31605 Phone: 229-247-2300 | |
Dr. Stanley Todd Alderman, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 114 W Cranford Ave, Valdosta, GA 31602 Phone: 229-247-2031 Fax: 229-247-9680 | |
Timothy T Grantham, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 103 W Cranford Ave, Valdosta, GA 31602 Phone: 229-249-0717 Fax: 229-249-0799 | |
Dr. Sherry C Colvin, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3901 Forrest Street Ext, Valdosta, GA 31605 Phone: 229-244-8884 Fax: 229-244-8874 | |
Dr. Fernando Alvarado, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3205 Wildwood Plantation Dr, Valdosta, GA 31605 Phone: 229-247-7585 Fax: 229-247-8901 |